We are on a mission to be the fastest growing biotech by 2030. And so, our goal is to continue to evolve our workforce so that we can better serve our patients with our solutions.

We had just gone through one of the largest acquisitions in pharma history. We acquired a new function called cell therapy, and it had a really unique skill set profile.

We did not have enough people with the right skills to be able to start to scale the solution of cell therapy. And so we started to explore with the business leader, taking a skills-based approach, which allowed us to focus on how do we hire differently, bring in different skill profiles, and then be able to build transferable skills.

Eightfold is demonstrating leadership in this space. So, being able to see the responsible AI and the ethics, and the position that the company takes on how we’re using AI was a key benefit for us, as well as they agreed to be a partner that would evolve with us.

One of the best things that we’ve been able to do is start to democratize access to opportunities within our workforce. So, when we launched the talent profile module, which basically gave everyone the ability to tell us about their skills, it opened up the access to see all of the possible career paths that their skills could open the doors with.

We’ve seen a lot of internal mobility, an increase of 30%. We’ve seen people move from the scientific areas into areas like HR and finance and vice versa.

And then we’ve also been able to redeploy talent. So where we’ve had to make organizational shifts and maybe decrease our focus in one area and increase in another area, we’ve been able to move talent, saving millions of dollars in potential severance costs and other factors associated with that. So it’s been very valuable.